117 related articles for article (PubMed ID: 37726528)
1. Proteomic landscape of primary and metastatic brain tumors for heterogeneity discovery.
Yang S; Zhou C; Zhang L; Xiong Y; Zheng Y; Bian L; Liu X
Proteomics Clin Appl; 2024 Mar; 18(2):e2300010. PubMed ID: 37726528
[TBL] [Abstract][Full Text] [Related]
2. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S
OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of brain metastatic lung adenocarcinoma reveals intertumoral heterogeneity and specific alterations associated with the timing of brain metastases.
Woldmar N; Schwendenwein A; Kuras M; Szeitz B; Boettiger K; Tisza A; László V; Reiniger L; Bagó AG; Szállási Z; Moldvay J; Szász AM; Malm J; Horvatovich P; Pizzatti L; Domont GB; Rényi-Vámos F; Hoetzenecker K; Hoda MA; Marko-Varga G; Schelch K; Megyesfalvi Z; Rezeli M; Döme B
ESMO Open; 2023 Feb; 8(1):100741. PubMed ID: 36527824
[TBL] [Abstract][Full Text] [Related]
4. Spatially resolved analysis of the T cell immune contexture in lung cancer-associated brain metastases.
Lu BY; Gupta R; Aguirre-Ducler A; Gianino N; Wyatt H; Ribeiro M; Chiang VL; Contessa JN; Adeniran AJ; Jilaveanu LB; Kluger HM; Schalper KA; Goldberg SB
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34670827
[TBL] [Abstract][Full Text] [Related]
5. Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas.
Wakimoto H; Tanaka S; Curry WT; Loebel F; Zhao D; Tateishi K; Chen J; Klofas LK; Lelic N; Kim JC; Dias-Santagata D; Ellisen LW; Borger DR; Fendt SM; Vander Heiden MG; Batchelor TT; Iafrate AJ; Cahill DP; Chi AS
Clin Cancer Res; 2014 Jun; 20(11):2898-909. PubMed ID: 24714777
[TBL] [Abstract][Full Text] [Related]
6. Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas.
Salloum R; McConechy MK; Mikael LG; Fuller C; Drissi R; DeWire M; Nikbakht H; De Jay N; Yang X; Boue D; Chow LML; Finlay JL; Gayden T; Karamchandani J; Hummel TR; Olshefski R; Osorio DS; Stevenson C; Kleinman CL; Majewski J; Fouladi M; Jabado N
Acta Neuropathol Commun; 2017 Oct; 5(1):78. PubMed ID: 29084603
[TBL] [Abstract][Full Text] [Related]
7. Antitumor mechanism of kangliu pill on gliomas in mice through PI3K-Akt signaling pathway.
Chen F; Cui JJ; Jiang DC; Wang HZ; Zhuang W; Feng YN; Lin XL; Xi SY
J Ethnopharmacol; 2023 May; 307():116252. PubMed ID: 36775078
[TBL] [Abstract][Full Text] [Related]
8. The IDH1 Mutation-Induced Oncometabolite, 2-Hydroxyglutarate, May Affect DNA Methylation and Expression of PD-L1 in Gliomas.
Mu L; Long Y; Yang C; Jin L; Tao H; Ge H; Chang YE; Karachi A; Kubilis PS; De Leon G; Qi J; Sayour EJ; Mitchell DA; Lin Z; Huang J
Front Mol Neurosci; 2018; 11():82. PubMed ID: 29643764
[No Abstract] [Full Text] [Related]
9. Integrated proteomic analysis of low-grade gliomas reveals contributions of 1p-19q co-deletion to oligodendroglioma.
Wong D; Lee TH; Lum A; Tao VL; Yip S
Acta Neuropathol Commun; 2022 May; 10(1):70. PubMed ID: 35526077
[TBL] [Abstract][Full Text] [Related]
10. Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases.
Nomura N; Pastorino S; Jiang P; Lambert G; Crawford JR; Gymnopoulos M; Piccioni D; Juarez T; Pingle SC; Makale M; Kesari S
Cancer Cell Int; 2014 Mar; 14(1):26. PubMed ID: 24645697
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy.
Pope WB; Prins RM; Albert Thomas M; Nagarajan R; Yen KE; Bittinger MA; Salamon N; Chou AP; Yong WH; Soto H; Wilson N; Driggers E; Jang HG; Su SM; Schenkein DP; Lai A; Cloughesy TF; Kornblum HI; Wu H; Fantin VR; Liau LM
J Neurooncol; 2012 Mar; 107(1):197-205. PubMed ID: 22015945
[TBL] [Abstract][Full Text] [Related]
12. Immunogenomic analysis of human brain metastases reveals diverse immune landscapes across genetically distinct tumors.
Álvarez-Prado ÁF; Maas RR; Soukup K; Klemm F; Kornete M; Krebs FS; Zoete V; Berezowska S; Brouland JP; Hottinger AF; Daniel RT; Hegi ME; Joyce JA
Cell Rep Med; 2023 Jan; 4(1):100900. PubMed ID: 36652909
[TBL] [Abstract][Full Text] [Related]
13. Multiscale, multimodal analysis of tumor heterogeneity in IDH1 mutant vs wild-type diffuse gliomas.
Berens ME; Sood A; Barnholtz-Sloan JS; Graf JF; Cho S; Kim S; Kiefer J; Byron SA; Halperin RF; Nasser S; Adkins J; Cuyugan L; Devine K; Ostrom Q; Couce M; Wolansky L; McDonough E; Schyberg S; Dinn S; Sloan AE; Prados M; Phillips JJ; Nelson SJ; Liang WS; Al-Kofahi Y; Rusu M; Zavodszky MI; Ginty F
PLoS One; 2019; 14(12):e0219724. PubMed ID: 31881020
[TBL] [Abstract][Full Text] [Related]
14. Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells.
Klemm F; Maas RR; Bowman RL; Kornete M; Soukup K; Nassiri S; Brouland JP; Iacobuzio-Donahue CA; Brennan C; Tabar V; Gutin PH; Daniel RT; Hegi ME; Joyce JA
Cell; 2020 Jun; 181(7):1643-1660.e17. PubMed ID: 32470396
[TBL] [Abstract][Full Text] [Related]
15. Expression of breast cancer metastasis suppressor-1, BRMS-1, in human breast cancer and the biological impact of BRMS-1 on the migration of breast cancer cells.
Zhang Y; Ye L; Tan Y; Sun P; Ji K; Jiang WG
Anticancer Res; 2014 Mar; 34(3):1417-26. PubMed ID: 24596389
[TBL] [Abstract][Full Text] [Related]
16. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
[TBL] [Abstract][Full Text] [Related]
17. Urinary biomarker discovery in gliomas using mass spectrometry-based clinical proteomics.
Wu J; Zhang J; Wei J; Zhao Y; Gao Y
Chin Neurosurg J; 2020; 6():11. PubMed ID: 32922940
[TBL] [Abstract][Full Text] [Related]
18. Multi-pronged proteomic analysis to study the glioma pathobiology using cerebrospinal fluid samples.
Gahoi N; Malhotra D; Moiyadi A; Varma SG; Gandhi MN; Srivastava S
Proteomics Clin Appl; 2018 May; 12(3):e1700056. PubMed ID: 28679024
[TBL] [Abstract][Full Text] [Related]
19. Novel 3D magnetic resonance fingerprinting radiomics in adult brain tumors: a feasibility study.
Tippareddy C; Onyewadume L; Sloan AE; Wang GM; Patil NT; Hu S; Barnholtz-Sloan JS; Boyacıoğlu R; Gulani V; Sunshine J; Griswold M; Ma D; Badve C
Eur Radiol; 2023 Feb; 33(2):836-844. PubMed ID: 35999374
[TBL] [Abstract][Full Text] [Related]
20. ZEB1 expression is increased in IDH1-mutant lower-grade gliomas.
Nesvick CL; Zhang C; Edwards NA; Montgomery BK; Lee M; Yang C; Wang H; Zhu D; Heiss JD; Merrill MJ; Ray-Chaudhury A; Zhuang Z
J Neurooncol; 2016 Oct; 130(1):111-122. PubMed ID: 27568035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
